Pathological complete response (pCR) and clinical outcomes [overall survival (OS), disease-free survival (DFS), locoregional control (LC)] were evaluated in a single-institution experience of different schedules of neoadjuvant chemoradiotherapy (CRT) for patients with locally advanced rectal cancer (LARC).
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes
DI Tommaso, MonicaPrimo
;Rosa, ConsueloSecondo
;Caravatta, Luciana
;Augurio, Antonietta;Borzillo, Valentina;Perrotti, Francesca;Taraborrelli, Maria;Innocenti, Paolo;DI Sebastiano, Pierluigi;Marchioni, Michele;DI Nicola, Marta;Genovesi, DomenicoUltimo
2020-01-01
Abstract
Pathological complete response (pCR) and clinical outcomes [overall survival (OS), disease-free survival (DFS), locoregional control (LC)] were evaluated in a single-institution experience of different schedules of neoadjuvant chemoradiotherapy (CRT) for patients with locally advanced rectal cancer (LARC).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
